Investors in Nutrition

Good Seed is a venture capital firm dedicated to enabling the production of safe and nutritious food for a growing population. They leverage their capital and industry-specific knowledge to accelerate the transition to a sustainable food system. Creating value-adding partnerships that support groundbreaking food entrepreneurs is what they thrive for. Their ambition is to foster the development and commercialization of industry-transforming food solutions so that everyone has access to delicious and healthy food.

HENRi is Nestle's flagship open innovation platform, launched in 2016. Unlocking the power of food to enhance quality of life for everyone, today and for generations to come. As the world’s largest food and beverage company we are driven by a simple aim: unlocking the power of food to enhance quality of life for everyone, today and for generations to come. HENRi

FoodLabs is a venture studio and investor for startups that shape the future of nutrition, sustainability and health. FoodLabs is a globally active Early Stage VC investor and venture studio, assisting the bold in building iconic companies committed to planetary and human health. Founded in 2016 by Christophe F. Maire, FoodLabs has built and invested in more than 80 early-stage companies.

ProVeg Incubator is the world's leading Incubator of plant-based and cultured food startups. The ProVeg Incubator, backed by ProVeg International, is the world's first and leading acceleration program for plant-based, fermentation, and cultured-food startups. We are shaping the future of food by exclusively supporting pioneering startups that are developing disruptive alternatives to animal-based products and services.

Founded in 2001, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

Roquette Ventures invests in food, nutrition, and health entrepreneurs.Roquette is a family-owned global leader in plant-based ingredients, specializing in plant proteins and pharmaceutical excipients. With a focus on innovation and sustainability, Roquette develops natural solutions for food, nutrition, and health market.

Newland Syndicate, we are operator-investors actively backing European Food & AgTech entrepreneurs. We specialize in early-stage investments across the entire food supply chain, from farm to fork. Our focus is on identifying visionary teams capable of creating new product categories and refining their execution strategies. We place great emphasis on backing founders who are pioneering novel systems for sustainable trading practices. Leveraging our extensive professional backgrounds in food, agriculture, retail, and technology, we provide invaluable support to entrepreneurs navigating the complexities of agrifood supply chains.

Mérieux Equity Partners is one of the most recognized and active European Investment firms in the Healthcare sector. We support the development and growth of high-potential companies from business launch to large scale deployment through capital investment and tailor-made support based on our strong sector expertise and international network. We are an agile investor with a flexible approach in terms of minority or majority stakes. Our main focus is partnering with and investing alongside management teams.

Evolem Start is a prominent family office managing $800 million in assets, dedicated to investing in French startups at the Seed and Series A stages. Sector-agnostic in its approach, Evolem Start seeks to identify and support high-potential companies across various industries. Their commitment to fostering innovation and growth in France is complemented by their strategic guidance and resources, helping startups navigate early-stage challenges and scale effectively.

Citizen Capital is a leading French private equity fund dedicated to using an impact-driven investment approach to deliver both financial and social returns for investors and society at-large. Citizen Capital manages €65 million and provides growth capital to high growth startups or SMEs (€1 to 50 million sales) with a strong social purpose targeting pressing social challenges (adressing the needs of underserved populations) or ecological needs (sustainable production and consumption). Our goal is to build wealth for all stakeholders in our portfolio companies as well as positive social impact for society at large. In addition to capital we offer a combination of strategic, financial, operational guidance to the companies in which we invest, as well as a pro-active support in building and driving impact strategy – Citizen Capital has implemented a methodology combining social impact and ESG approach. Citizen Capital is B Corp certified, has signed the Principles for Responsible Investment (United Nations, PRI) and is a member of the G8 Social Impact Investment Task Force.

BHV Partners is a venture builder specializing in creating healthcare startups by leveraging research and technology from academic and medical institutions. They collaborate closely with scientists to co-found ventures that address medical gaps, providing strategic guidance across technological, corporate, and funding aspects to enhance startup success and longevity. BHV Partners also offers consulting services to technology transfer offices and the biomedical industry. Recognized for their impact, they were named among the top 15 healthcare startups transforming patient care by EU Startup News in 2023.

They are a growth equity firm focused on empowering visionary founders who innovate in brands and tech-enabled solutions that improve lives while promoting inclusivity. They seek unstoppable founders who anticipate future challenges, emphasizing responsible innovation, diversity, transparency, and positive change. Operating as true partners, they offer extensive operational and strategic support, leveraging a broad network to enhance consumer experiences through community, branding, innovation, and technology. With a global outlook, they invest in Series A rounds and later-stage co-investments across Europe, the UK, US, and Asia, aiming to build a more human-centered digital-lifestyle future.